 |
|
|
| |
No increase in the occurrence rate of HCC in Chinese treated by DAAs compared to PR after eradication of HCV: a long-term follow-up
|
| |
| |
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Dong Ji*1,2,,Cheng Wang2,3,4,,Qing Shao1,2,Fan Li1,2,Bing Li1,2,Vanessa Wu2,3,April Wong4,Yu D.Wang2,3,Jing Chen2,3,Guo F.Chen1,2,George Lau2,3,5
1Second Liver Cirrhosis Diagnosis and Treatment Center, Beijing 302 Hospital, Beijing, China,
2Beijing302-Hong Kong Humanity and Health Hepatitis C Diagnosis and Treatment Centre, Beijing 302 Hospital, Beijing, China, 3Division of Gastroenterology & Hepatology, Humanity & Health Medical Centre, Hong Kong, China, 4State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou,
5Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, China
|
| |
|
|
|
|
|
